Therefore, in view of the complexity of tumor occurrence and progression in BRCA (breast invasive carcinoma), it is of great importance for us to clarify the correlation between MYL5 and clinical prognosis, as well as the potential molecular mechanism of great significance in breast cancer. This evidence concerns the gene MYL5 and breast carcinoma.